Carlyle Secured Lending, Inc. heads into the back half of May with a fresh set of headwinds: a cut base dividend, a weaker-than-expected Q1, and a steady stream of downward analyst target revisions landing just as the stock loses nearly 7% on the week.
The Q1 print, released on May 11, was the week's defining event. Net investment income came in below benchmark, and management announced a reset of the base dividend to $0.35 per share from $0.40 — a 12.5% cut. The stock fell 2.3% on the day of the earnings release, extending a month-long slide that has brought shares to $11.25. The company did outline plans to price two additional CLOs in 2026, and cited roughly $0.86 per share in spillover income as a cushion. But the income cut was the headline, and the market treated it as one.
The analyst response this week crystallised the cautious mood. Wells Fargo's Finian O'Shea cut his price target to $12 from $13 on May 13 while holding an Overweight rating — his third consecutive target reduction since July 2025, when he upgraded with a $15 target. B. Riley Securities moved the other way, raising its Neutral target to $13.50 from $13 on May 12. JP Morgan's March cut to $10 (Neutral) frames the low end of Street expectations. The consensus has drifted to Hold, with the mean target near $13.35 — about 19% above the current price, though the wide dispersion between JP Morgan's $10 and a prior Wells Fargo $12 reflects genuine disagreement on NAV trajectory. The analyst data field is from late 2025 for the consensus level; the recent individual actions are current and carry more weight here. Short interest tells a less aggressive story than the price action might suggest. Shorts added about 17% over the past month to reach roughly 3.1 million shares, and rose 1.8% on the week — a gentle build rather than a conviction short. The ORTEX short score of 57.0 is in moderate territory, below the 74.4 peak seen in the past year. Borrowing costs run near 4.9% — elevated for a BDC but not extreme, and down 8% over the past week. Borrow availability has loosened materially this week, with roughly half the lending pool now free after availability had tightened to near 30% in late April. That easing signals no acute squeeze pressure, even as the share count on loan has crept higher.
as_ofOptions positioning is tilted heavily toward calls. The put/call ratio is at just 0.03, well below its 20-day average of 0.045 and near the 52-week low of 0.0275. That extreme call-skew appears to reflect thin options activity rather than outright bullishness — the PCR was near 0.14 through most of March and April before collapsing in late April. With such a low put/call ratio, there is no meaningful options-driven hedge demand visible on this name.
Management's own actions provide a counterpoint worth noting. In March, the CEO bought 9,000 shares at $10.79 and the CFO, Thomas Hennigan, picked up 4,430 shares at $11.26. That follows a pattern: Hennigan also bought approximately $100,000 worth of shares in both November 2025 and August 2025. Over the past 90 days, insiders were net buyers of roughly 18,000 shares for about $199,000. An independent director, John Nestor, has been a consistent seller on the other side, though in smaller amounts. The CEO and CFO cluster of purchases at prices below current NAV stands out as a signal that management sees the book as durable, even as external analysts trim targets.
Closest peer OBDC fell 6.2% on the week, and CCAP dropped 5.0%, suggesting broad BDC sector weakness rather than a CGBD-specific trade. ARCC, the sector's bellwether, held somewhat better at -3.0%, while GBDC lost only 1.8%. CGBD's 6.9% weekly decline is toward the sharper end of the peer range, consistent with the dividend cut amplifying the sector drawdown.
The next earnings event is scheduled for June 9. Between now and then, the key variables to watch are whether NAV stabilises near the current price-to-book of 0.70x, whether the CLO pipeline announcements translate into visible portfolio growth, and whether the new $0.35 dividend level proves sustainable against net investment income in Q2.
See the live data behind this article on ORTEX.
Open CGBD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.